Shijiazhuang Yiling Pharmaceutical Co Ltd SZSE:002603:
SAYS Q3 NET PROFIT UP 1264.6% Y/Y
Yiling Pharmaceutical Q3 Net Profit Up 1264.6% Y/Y
Earlier from Shijiazhuang Yiling Pharmaceutical Co., Ltd. Class A
- Shijiazhuang Yiling Pharmaceutical Co: Net profit rose 26% to ¥669 million despite a 12% revenue drop, with strong cash flow
- Shijiazhuang Yiling Pharmaceutical Co: Net profit grew 7.25% year-over-year in Q1 2025 despite a 6.52% revenue drop
- Shijiazhuang Yiling Pharmaceutical Co: 2024 net loss driven by sales drop, inventory write-downs, and high R&D; cost control prioritized
- Shijiazhuang Yiling Pharmaceutical Co: Revenue and profit declined sharply year-over-year, but operating cash flow improved